British Journal of Pharmacology · 2001 · 29 citations · 10 references
MedicineNeurosciencePharmacologyNeurochemistryNeuropharmacologyPharmacodynamicsBotulinum Toxin TherapyBotulinum Toxin TreatmentNeuromodulationNeuromuscular Blocking AgentsNeuroprotectionBotulinum NeurotoxinBotulinum ToxinsInhibitory TransmissionNatural Antitoxin CompoundsPlant Toxin PharmacologyTherapeutic Toxin Applications
Botulinum neurotoxin type A (BoNT/A, 1.5 nM) completely inhibited indirectly evoked twitches in in vitro mouse phrenic nerve-diaphragm preparations within 40 - 45 min. Black tea extract, thearubigin fraction (TRB), mixed with BoNT/A blocked the inhibitory effect of the toxin. The protective effect of TRB extended to botulinum neurotoxins types B and E (BoNT/B and BoNT/E) and tetanus toxin, but not to tetrodotoxin. TRB was also effective against oral toxicity of BoNT/A, B and E. Thus, TRB may be of potential benefit in protecting the paralytic actions of botulinum neurotoxins (BoNTs), but its use is limited by mixing with the toxin.
10
Polyphenol–protein interactions
Edwin Haslam · Biochemical Journal · 1974 · 305 citations · Full text
Antioxidant properties of fractions and polyphenol constituents from green, oolong and black teas.
Boyan Xie, H. Shi, Qiang Chen et al. · PubMed · 1993 · 102 citations
Botulinum toxin: from poison to remedy.
Kirn R. Kessler, R. Benecke · PubMed · 1997 · 57 citations